Abamune 300mg Tablet

Abamune 300mg Tablet – Abacavir 300 mg by Cipla

Abamune 300 mg Tablet contains Abacavir 300 mg (as Abacavir Sulphate IP) and is a nucleoside reverse transcriptase inhibitor (NRTI) used in combination antiretroviral therapy for HIV-1 infection. Manufactured by Cipla Ltd. at MIDC Patalganga (M.L. 845), each film-coated tablet works by blocking reverse transcriptase, the enzyme HIV needs to copy itself, which lowers the viral load and helps the CD4 count recover. Supplied as a pack of 30 tablets. This is a Schedule H prescription drug and is dispensed only against a valid prescription.

Key Features

• Abacavir 300 mg film-coated tablet, Indian Pharmacopoeia grade
• NRTI backbone agent used in combination ART regimens
• Can be taken with or without food
• Schedule H – prescription and medical supervision required

Composition

• Abacavir (as Abacavir Sulphate IP) – 300 mg per film-coated tablet
• Colours – Yellow Oxide of Iron and Titanium Dioxide IP

Uses & Benefits

• Treatment of HIV-1 infection in combination with other antiretroviral medicines
• Reduces the amount of virus in the blood (viral load)
• Supports recovery of CD4 white blood cell counts
• Helps lower the risk of HIV-related infections and complications
• Improves long-term quality of life when taken consistently
• Flexible dosing – may be taken with or without food

Directions for Use

• Take exactly as prescribed by your doctor – dose and schedule are individual
• Swallow the tablet whole with water; do not chew, crush or break it
• Take at the same time each day to keep blood levels steady
• Never stop or change the dose on your own, even if you feel well
• If you miss a dose, take it as soon as you remember unless the next dose is near – do not double up

Precautions

• HLA-B*5701 screening before starting abacavir is recommended by treatment guidelines
• Common side effects include headache, nausea, vomiting, fever, tiredness, dizziness, loss of appetite, muscle pain, diarrhoea, rash and altered liver enzymes
• Use with caution in liver or kidney disease; dose review may be needed
• Avoid alcohol; tell your doctor if you are pregnant, planning pregnancy or breastfeeding
• May cause dizziness – do not drive until you know how it affects you

Storage

• Store below 30°C in a dry place
• Keep in the original carton, protected from light and moisture
• Keep out of reach of children

Disclaimer

Schedule H prescription drug – not to be sold by retail without the prescription of a Registered Medical Practitioner. This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Antiretroviral therapy must be started, changed and monitored only by a qualified HIV specialist.